Illumina’s CEO Jacob Thaysen Drives Strategic Growth as Q4 Revenue Surpasses Expectations

      Illumina, led by CEO Jacob Thaysen, delivered a Q4 revenue of $1.1 billion, reflecting a steady 1% year-over-year increase, w...

February 07, 2025 | Friday | Company results
BD Reports Strong Q1 2025 Results with $5.2B Revenue as CEO Tom Polen Announces Strategic Business Separation

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,  announced its financial results for the first quarter ...

February 06, 2025 | Thursday | Company results
Merck (Known as MSD Outside the U.S. & Canada) Reports Strong 2024 Growth – CEO Robert M. Davis Highlights KEYTRUDA, WINREVAIR, and Pipeline Momentum

Fourth-Quarter Worldwide Sales Were $15.6 Billion, an Increase of 7% From Fourth Quarter 2023; Excluding the Impact of Foreign Exchange, Growth W...

February 04, 2025 | Tuesday | Company results
Albert Bourla Leads Pfizer to $63.6B Triumph in 2024 – Record Growth, Bold Strategy, and a Sharpened Vision for 2025!

Pfizer Inc. reported robust financial results for the full year 2024, achieving total revenues of $63.6 billion, reflecting a 7% year-over-year operation...

February 04, 2025 | Tuesday | Company results
Novartis Posts 12% Sales Growth in 2024 as CEO Vas Narasimhan Sets Sights on Stronger 2025

Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance from Ent...

January 31, 2025 | Friday | Company results
Lonza Delivers CHF 6.6 Billion in 2024 Sales as CEO Wolfgang Wienand Drives One Lonza Strategy

In 2024, Lonza delivered sales of CHF 6.6 billion in line with prior year (-0.2% CER1) CORE EBITDA of CHF 1.9 billion at a margin of 29.0% The CDMO...

January 31, 2025 | Friday | Company results
Marc N. Casper on Thermo Fisher's Strong 2024 Finish: "We Drove Meaningful Growth, Positioned for Excellence in 2025

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year...

January 30, 2025 | Thursday | Company results
Serum Institute of India CEO Adar Poonawalla Advocates for Equitable Healthcare Access at World Economic Forum 2025 in Davos

At the prestigious World Economic Forum 2025, Adar Poonawalla, CEO of Serum Institute of India Pvt. Ltd., joined the influential panel ‘Health and ...

January 27, 2025 | Monday | News
Labviva CEO Siamak Baharloo on Transforming Life Sciences Procurement with Innovation and AI

In a conversation with BioPharma BoardRoom, Siamak Baharloo, the visionary Co-founder and CEO of Labviva, delves into the transformative role of technology...

January 22, 2025 | Wednesday | Interview
NVIDIA's CEO Jensen Huang Highlights AI Advancements in Healthcare at J.P. Morgan Conference

AI is making inroads across the entire healthcare industry — from genomic research to drug discovery, clinical trial workflows and patient care. I...

January 15, 2025 | Wednesday | News
BIO President John F. Crowley Calls for Equitable Access to Breakthrough Therapies at White House Cell and Gene Therapy Forum

  As the science of cell and gene therapies (CGT) reaches unprecedented heights, equitable access to these lifesaving treatments must keep pace, said...

January 14, 2025 | Tuesday | News
Meeta Gulyani Joins Ecolab to Lead Bioprocessing Growth and Drive Life Science Strategy

  Ecolab, a global leader in water, hygiene, and infection prevention solutions, proudly announces the appointment of Meeta Gulyani as the General Ma...

January 10, 2025 | Friday | News
Briggs Morrison, M.D., Joins CRISPR Therapeutics to Propel Innovation in Gene Editing

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced it ...

January 08, 2025 | Wednesday | News
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Precision Medicine and Gene Synthesis for 2025

In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advanc...

December 12, 2024 | Thursday | Interaction

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close